Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer.

Published in: Recent patents on anti-cancer drug discovery (2024)

Elevated expression of HMGA2-AS1 in GC patients exhibited a significant correlation with unfavorable survival outcomes and increased immune infiltration. This suggests that HMGA2- AS1 holds promise as a potential prognostic biomarker and target for immunotherapy in GC.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
poor prognosis
peritoneal dialysis
prognostic factors
binding protein
long non coding rna
risk assessment
big data
mass spectrometry
deep learning